IVX
INVION FPO [IVX]
Healthcare · ASX Small Cap
$0.0790 -1.2%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score +10First seen: 2026-02-25
Score Breakdown
Technical28
Catalyst50
Sentiment50
Fundamental13
Momentum41
Risk Gate35
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Sustained volume spike (3.5x median) on DOWN trend
- Critical cash runway (1.1 quarters)
- 4C filed 2026-01-30
- Very high P/S ratio (2272.6x)
- Revenue in sharp decline (-100%)
- Near 52-week low (4% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- Altman Z-Score in distress zone (0.52 < 1.81)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2015-06)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-100%)
Recent Catalysts
NONE Appendix 4D and Half Year Financial Report
NONE Notification regarding unquoted securities - IVX
NONE Proposed issue of securities - IVX
LOW Emergence 2026 Investor Presentation
LOW Appendix 4C and Quarterly Activities Report - December 2025
Recent ASX Announcements
| 2026-02-26 | Appendix 4D and Half Year Financial Report PRICE SENSITIVE |
| 2026-02-18 | Emergence 2026 Investor Presentation |
| 2026-02-18 | Notification regarding unquoted securities - IVX |
| 2026-01-30 | Appendix 4C and Quarterly Activities Report - December 2025 PRICE SENSITIVE |
| 2026-01-30 | Proposed issue of securities - IVX |
Key Metrics
$6.9M
Market Cap
121K
Avg Volume
3.5x
Vol Ratio
$0.07 — $0.20
52-Week Range
N/A
Short Interest
1 qtrs
Cash Runway
-77.6%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 61% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #94 of 119 · Sector avg: 51
View all Healthcare signals →